Sawyer & Company, Inc Gsk PLC Transaction History

Sawyer & Company, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 14, 2022	SELL	$38.88 - $45.31 $4,860 - $5,663	-125 Closed	0 $0
Q1 2021 Apr 22, 2021	SELL	$34.27 - $40.01 $11,994 - $14,003	-350 Reduced 73.68%	125 $4,000
Q4 2020 Jan 26, 2021	SELL	$34.07 - $39.94 $11,924 - $13,979	-350 Reduced 42.42%	475 $17,000
Q3 2020 Oct 20, 2020	SELL	$38.11 - $42.99 $21,913 - $24,719	-575 Reduced 41.07%	825 $31,000
Q4 2018 Jan 25, 2019	SELL	$37.8 - $42.69 $33,075 - $37,353	-875 Reduced 38.46%	1,400 $53,000
Q4 2017 Jan 11, 2018	BUY	$35.34 - $41.9 $80,398 - $95,322	2,275	2,275 $81,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Sawyer & Company, Inc, based on Form 13F filings with the SEC.

Stay updated on Sawyer & Company, Inc with notifications on news.